Navigation Links
MacroGenics Raises $25M in Series D-2 Financing
Date:9/25/2008

Proceeds to be Used for Advancement of Cancer Stem Cells and Other

Development Programs

ROCKVILLE, Md., Sept. 25 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it has raised $25 million in a Series D-2 financing. The round, led by Nextech Venture, included additional new investors Arcus Ventures, Innovis Investments and Eli Lilly and Company. Also participating in the financing were existing investors Alexandria Real Estate, Alta Partners, CIDC, InterWest Partners, Mitsubishi UFJ, OrbiMed Advisors, Red Abbey Venture Partners, RiverVest, Texas Pacific Group Ventures and Ventures West.

MacroGenics expects to use the proceeds from this financing to fund the cancer stem cell program it acquired through its acquisition of Raven Biotechnologies in July. In addition, the proceeds will be used to further advance the company's autoimmune, cancer and infectious disease product candidate portfolio, as well as for general working capital purposes. MacroGenics' most advanced product candidate is teplizumab, which is being developed in partnership with Eli Lilly and Company. Teplizumab is currently being studied in the PROTEGE trial, a global pivotal Phase II/III clinical trial for individuals with recent-onset type 1 diabetes.

"We are delighted to add Nextech Venture, Arcus Ventures and Innovis Investments, three oncology-focused investors, as well as Eli Lilly and Company to our roster of blue chip shareholders. Our experienced investor syndicate provides critical support to MacroGenics as we drive our programs through clinical development towards commercialization," commented Dr. Scott Koenig, President and CEO of MacroGenics. "In addition, with the recent acquisition of Raven Biotechnologies and the addition of their exciting technologies to our own platforms, we are planning
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MacroGenics Acquires Raven Biotechnologies
2. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
3. Yongye Biotechnology International Raises $9.4 Million in Private Placement
4. Proteolix Raises $79 Million in Series C Financing
5. Bacon Eating Contest Raises Money for American Heart Association
6. Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
7. Pacific Biosciences Raises $100 Million to Fund Commercial Product Development
8. Alseres Pharmaceuticals, Inc. Raises $5 Million
9. BSP Raises $2.6 Million Dollars From Private Investors
10. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
11. Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... DUBLIN , Sept. 22, 2014 ... the "Global and Chinese Microcrystalline Cellulose Industry Report ... The Global and Chinese Microcrystalline Cellulose Industry Report 2014 ... state of the global microcrystalline cellulose industry with a ... provides a basic overview of the industry including definitions, ...
(Date:9/22/2014)... Washington, D.C (PRWEB) September 22, 2014 ... the top privately held biotechnology companies of 2014. ... of companies before selecting this year’s winners. Those ... private biotechnology companies in the industry. , ... a new group of Fierce 15 companies," said Carroll. ...
(Date:9/22/2014)... Sept. 22, 2014 Synageva BioPharma ... a biopharmaceutical company developing therapeutic products for rare ... Bazemore as Chief Operating Officer.  Reporting directly ... Chief Executive Officer, Robert will oversee the planned ... sebelipase alfa for LAL Deficiency, and will have ...
(Date:9/21/2014)... Chemical Sciences play a significant role ... air and safe water, healthy food, and dependable ... food scientists, educators, and scientists have a great ... of Chemistry for the national development, and to ... the fastest emerging Sciences, accelerating with a tremendous ...
Breaking Biology Technology:Global and Chinese Microcrystalline Cellulose Industry Report 2014 2FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3
... , , Mark Churchill 1 , Mark Harrison 1 , , ... , 1 Thermo Finnigan, Stafford House, 1 Boundary Park, Boundary Way, ... Aker University Hospital, Hormone Laboratory, Section for Doping Analysis,Trondheimsveien, , N-0514, Oslo, Norway, ... , Monitoring Clenbuterol in Humans , , , ...
... , , , , , , , ... , Features and benefits , , , , , ... transfection of siRNA for effective gene silencing , Quick and easy setup ... for absence of RNase activity , , , , , ...
... , , , , QIAshredder spin columns are designed for simple and rapid ... , , , , ... , , , ... tissue lysates, , plant cell or tissue lysates, white blood cell lysates, ...
Cached Biology Technology:Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 2Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 3Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 4Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 5TransMessenger Transfection Reagent 2TransMessenger Transfection Reagent 3QIAshredder Homogenizer 2
(Date:9/21/2014)... developed a protein therapy that disrupts the process that ... sites, travel through the blood stream and start aggressive ... known as metastasis, can cause cancer to spread with ... succumb to cancer fall prey to metastatic forms of ... bioengineering who describes a new therapeutic approach in ...
(Date:9/19/2014)... The sense of fairness did not evolve for the ... reap the benefits of continued cooperation, so say Frans ... a review article about inequity aversion (IA), which is ... review is published in Science . , ... 35 IA-related studies to address their hypothesis that it ...
(Date:9/18/2014)... A new GSA Bulletin study uses ... Rio Puerco and Chaco Wash in northern New Mexico, ... salt cedar and willow, investigators were able to precisely ... They then combined this data with aerial imagery, LiDAR, ... of these arroyos. , Arroyos are deep, oversized channels ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... When researchers sequence the RNA of cancer cells, they can ... RNA. That can help lead them to the gene or protein ... a few known instigators, what does it mean? Is there more ... fast enough? What part of the biological equilibrium is off? ...
... the first time that primates modify their body movements to ... Humans unconsciously modify their movements to be in synchrony with ... in step or clap in unison at the end of ... facilitate human interaction. Researchers from the RIKEN Brain Science Institute ...
... patients with an inherited heart condition known as arrhythmogenic ... problem until they,re in their early 20s. The lack ... for researchers to study how ARVD/C evolves or to ... 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps ...
Cached Biology News:New technique sheds light on RNA 2Primates too can move in unison 2Patients' own skin cells are transformed into heart cells to create 'disease in a dish' 2Patients' own skin cells are transformed into heart cells to create 'disease in a dish' 3
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
... Anti-NY-ESO-1, clone E978 ... : NM_001327 Immunogen ... protein Formulation: mouse ascites ... Quality Assurance: routinely evaluated ...
R26.4C...
Biology Products: